Abiopharma

🔍 Ninivaggi Angelo Michael Jr (Executive)

Company: PLEXUS CORP (PLXS)

Report Date: 2026-05-07

Detailed Transactions and Holdings:

• Sold 1,294 shares of Common Stock, $.01 par value at $262.4286 per share (Direct)
  Date: 2026-05-07 | Code: S | equity_swap_involved: 0 | shares_owned_after: 20,540.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 945 shares of Common Stock, $.01 par value at $263.6606 per share (Direct)
  Date: 2026-05-07 | Code: S | equity_swap_involved: 0 | shares_owned_after: 19,595.00 | transaction_form_type: 4 | Footnotes: F2
• Sold 59 shares of Common Stock, $.01 par value at $264.3791 per share (Direct)
  Date: 2026-05-07 | Code: S | equity_swap_involved: 0 | shares_owned_after: 19,536.00 | transaction_form_type: 4 | Footnotes: F3
• Sold 1,484 shares of Common Stock, $.01 par value at $264.1137 per share (Direct)
  Date: 2026-05-08 | Code: S | equity_swap_involved: 0 | shares_owned_after: 18,052.00 | transaction_form_type: 4 | Footnotes: F4
• Sold 1,562 shares of Common Stock, $.01 par value at $265.1768 per share (Direct)
  Date: 2026-05-08 | Code: S | equity_swap_involved: 0 | shares_owned_after: 16,490.00 | transaction_form_type: 4 | Footnotes: F5
• Sold 224 shares of Common Stock, $.01 par value at $266.0064 per share (Direct)
  Date: 2026-05-08 | Code: S | equity_swap_involved: 0 | shares_owned_after: 16,266.00 | transaction_form_type: 4 | Footnotes: F6

Footnotes:

• F1: This transaction was executed in multiple trades at prices ranging from $262.00 to $262.94 per share. The reported price reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F2: This transaction was executed in multiple trades at prices ranging from $263.24 to $263.855 per share. The reported price reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F3: This transaction was executed in multiple trades at prices ranging from $264.04 to $264.49 per share. The reported price reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F4: This transaction was executed in multiple trades at prices ranging from $263.825 to $264.63 per share. The reported price reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F5: This transaction was executed in multiple trades at prices ranging from $264.88 to $265.815 per share. The reported price reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F6: This transaction was executed in multiple trades at prices ranging from $265.97 to $266.20 per share. The reported price reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.